Form 4 for GYRE GYRE THERAPEUTICS, INC.
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-01 · accession 0001209191-21-059433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-05 | 2021-10-01 | GYRE | Ling Geoffrey M.D. | Dir | A - Grant | $0.00 | +2,858 | 18.9K | +18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-01 | A | A | 2,858 | $0.00 | 18,935 | D | — | — | (F1) Represents shares of common stock received in lieu of fees. |